Autolus Therapeutics PLC (AUTL) is down 29.43% Friday In Premarket Trading

Autolus Therapeutics PLC (AUTL) is down Friday morning, with the stock declining -29.43% in pre-market trading to 2.11. AUTL's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, AUTL ranks higher than 18% of stocks. Autolus Therapeutics PLC has risen 45.15% over the past month, closing at $2.22 on November 11. During this period of time, the stock fell as low as $2.00 and as high as $3.53. AUTL has an average analyst recommendation of Strong Buy. The company has an average price target of $10.40.

AUTL has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on AUTL!

See Full AUTL Report

Autolus Therapeutics PLC has a Long-Term Technical rank of 50. This means that trading over the last 200 trading days has placed the company in the middle with 50% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, AUTL ranks better than 130% of stocks.

Important Dates for Investors in AUTL:

-Autolus Therapeutics PLC is set to release earnings on 2/1/2023. Over the last 12 months, the company has reported EPS of $-1.85. -We do not have a set dividend date for Autolus Therapeutics PLC at this time. Click Here To Get The Full Report on Autolus Therapeutics PLC (AUTL)